118 related articles for article (PubMed ID: 11041453)
1. No evidence of thyrotropin receptor and G(s alpha) gene mutation in high iodine uptake thyroid carcinoma.
Bourasseau I; Savagner F; Rodien P; Duquenne M; Reynier P; Guyetant S; Bigorgne JC; Malthièry Y; Rohmer V
Thyroid; 2000 Sep; 10(9):761-5. PubMed ID: 11041453
[TBL] [Abstract][Full Text] [Related]
2. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.
Parma J; Duprez L; Van Sande J; Hermans J; Rocmans P; Van Vliet G; Costagliola S; Rodien P; Dumont JE; Vassart G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2695-701. PubMed ID: 9253356
[TBL] [Abstract][Full Text] [Related]
3. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.
Spambalg D; Sharifi N; Elisei R; Gross JL; Medeiros-Neto G; Fagin JA
J Clin Endocrinol Metab; 1996 Nov; 81(11):3898-901. PubMed ID: 8923835
[TBL] [Abstract][Full Text] [Related]
5. The trapping-only nodules of the thyroid gland: prevalence study.
Reschini E; Ferrari C; Castellani M; Matheoud R; Paracchi A; Marotta G; Gerundini P
Thyroid; 2006 Aug; 16(8):757-62. PubMed ID: 16910877
[TBL] [Abstract][Full Text] [Related]
6. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
[TBL] [Abstract][Full Text] [Related]
7. Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes.
Ruggeri RM; Campennì A; Giovinazzo S; Saraceno G; Vicchio TM; Carlotta D; Cucinotta MP; Micali C; Trimarchi F; Tuccari G; Baldari S; Benvenga S
Thyroid; 2013 Feb; 23(2):239-42. PubMed ID: 22985488
[TBL] [Abstract][Full Text] [Related]
8. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
Matsuo K; Friedman E; Gejman PV; Fagin JA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas.
Cetani F; Tonacchera M; Pinchera A; Barsacchi R; Basolo F; Miccoli P; Pacini F
J Endocrinol Invest; 1999 Apr; 22(4):273-8. PubMed ID: 10342361
[TBL] [Abstract][Full Text] [Related]
10. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.
Collins MT; Sarlis NJ; Merino MJ; Monroe J; Crawford SE; Krakoff JA; Guthrie LC; Bonat S; Robey PG; Shenker A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4413-7. PubMed ID: 12970318
[TBL] [Abstract][Full Text] [Related]
11. A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis.
Russo D; Wong MG; Costante G; Chiefari E; Treseler PA; Arturi F; Filetti S; Clark OH
Thyroid; 1999 Jan; 9(1):13-7. PubMed ID: 10037070
[TBL] [Abstract][Full Text] [Related]
12. Absence of activating mutations of the genes encoding the alpha-subunits of G11 and Gq in thyroid neoplasia.
Ringel MD; Saji M; Schwindinger WF; Segev D; Zeiger MA; Levine MA
J Clin Endocrinol Metab; 1998 Feb; 83(2):554-9. PubMed ID: 9467574
[TBL] [Abstract][Full Text] [Related]
13. A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism.
Camacho P; Gordon D; Chiefari E; Yong S; DeJong S; Pitale S; Russo D; Filetti S
Thyroid; 2000 Nov; 10(11):1009-12. PubMed ID: 11128715
[TBL] [Abstract][Full Text] [Related]
14. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?
Gozu H; Avsar M; Bircan R; Sahin S; Ahiskanali R; Gulluoglu B; Deyneli O; Ones T; Narin Y; Akalin S; Cirakoglu B
Thyroid; 2004 Nov; 14(11):975-80. PubMed ID: 15671779
[TBL] [Abstract][Full Text] [Related]
15. Absence of G(s)alpha gene mutations in childhood thyroid tumors after Chernobyl in contrast to sporadic adult thyroid neoplasia.
Waldmann V; Rabes HM
Cancer Res; 1997 Jun; 57(12):2358-61. PubMed ID: 9192808
[TBL] [Abstract][Full Text] [Related]
16. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.
Russo D; Tumino S; Arturi F; Vigneri P; Grasso G; Pontecorvi A; Filetti S; Belfiore A
J Clin Endocrinol Metab; 1997 Mar; 82(3):735-8. PubMed ID: 9062474
[TBL] [Abstract][Full Text] [Related]
17. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes.
Niepomniszcze H; Suárez H; Pitoia F; Pignatta A; Danilowicz K; Manavela M; Elsner B; Bruno OD
Thyroid; 2006 May; 16(5):497-503. PubMed ID: 16756473
[TBL] [Abstract][Full Text] [Related]
18. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
19. Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases.
Führer D; Tannapfel A; Sabri O; Lamesch P; Paschke R
Endocr Relat Cancer; 2003 Dec; 10(4):591-600. PubMed ID: 14713269
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of toxic thyroid adenomas and nodules: relevance of activating mutations in the TSH-receptor and Gs-alpha gene, the possible role of iodine deficiency and secondary and TSH-independent molecular mechanisms.
Derwahl M; Manole D; Sobke A; Broecker M
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S6-9. PubMed ID: 9867188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
